ClinicalTrials.Veeva

Menu

Preeclampsia Subtypes and Surrogate Markers of CVD Risk

University of Aarhus logo

University of Aarhus

Status

Unknown

Conditions

Preeclampsia

Study type

Observational

Funder types

Other

Identifiers

NCT02337049
26702017

Details and patient eligibility

About

In order to assess surrogate markers of cardiovascular risk in subtypes of preeclampsia, we will conduct a 10-year follow-up study comparing 40 women with a history of early onset preeclampsia; 40 women with a history of late onset preeclampsia and 40 women with a history of normotensive pregnancies.

Eligible participants delivered at the Department of Obstetrics at Randers Regional Hospital 1998-2008.

Early-onset preeclampsia is defined as preeclampsia that develops before 34 weeks of gestation, whereas late-onset preeclampsia develops at or after 34 weeks of gestation.

Enrollment

120 estimated patients

Sex

Female

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Women who delievered at the Department of Obstetrics at Randers Regional Hospital 1998-2008

Exclusion criteria

  • Current pregnancy or breastfeeding

Trial design

120 participants in 3 patient groups

Previously early onset preeclampsia
Description:
Women with a history of early onset preeclampsia 10 years ago
Previously late onset preeclampsia
Description:
Women with a history of late onset preeclampsia 10 years ago
Previously normotensive pregnancy
Description:
Women with a history of normotensive pregnancies 10 years ago

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems